Cargando…
LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells: LIMT contributes to sorafenib chemoresistance in HCC
Hepatocellular carcinoma (HCC) is one of the most malignant tumors worldwide and HCC patients often develop drug resisitene. Long non-coding RNAs (LncRNAs) are closely related to cell cycle, growth, development, differentiation, and apoptosis. Abnormally expressed lncRNAs have been proved to mediate...
Autores principales: | Sun, Jing, Zheng, Xiaoxiao, Wang, Baoming, Cai, Ying, Zheng, Li, Hu, Liqiang, Lu, Xuemei, Xie, Shangzhi, Zhang, Xin, Liu, Hao, Ye, Longyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909357/ https://www.ncbi.nlm.nih.gov/pubmed/35130616 http://dx.doi.org/10.3724/abbs.2021019 |
Ejemplares similares
-
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer
por: Sas‐Chen, Aldema, et al.
Publicado: (2016) -
The long non-coding RNA LIMT inhibits metastasis of hepatocellular carcinoma and is suppressed by EGF signaling
por: Hu, Yu, et al.
Publicado: (2022) -
Treatment of chronic hepatitis D with peginterferon lambda—the phase 2 LIMT-1 clinical trial
por: Etzion, Ohad, et al.
Publicado: (2023) -
M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression
por: Zeng, Xiang-Yang, et al.
Publicado: (2019) -
Incapacitated Capicua in Sorafenib-Resistant HCC
por: Yin, Dingzi, et al.
Publicado: (2020)